Posts

STAT+: Lasers, cardiology, clinical trials: 2023’s top ...

Private equity investment in health care ramped up in three sectors: cardiology,...

STAT+: A junior scientist. A prominent oncologist. Now,...

It’s not uncommon for scientists to disagree over authorship. But it’s highly un...

STAT+: Key House Republican on health care plans exit f...

Rep. Cathy McMorris Rodgers, who leads the House Energy & Commerce Committee, an...

STAT+: Senate Democrats push for stronger rules around ...

Senate Democrats wants Medicare to take more aggressive action to prevent health...

Listen: AI in medicine, detangling hype, and Icelandic DNA

This week on "The Readout LOUD": Has AI really solved biology? What can machines...

In a showy hearing, Bernie Sanders gets few answers abo...

In a jam-packed hearing room, Sen. Bernie Sanders pressed CEOs with familiar que...

Higher naloxone doses have no impact on overdose surviv...

Companies have been pushing high-dose versions of naloxone to reverse overdose, ...

STAT+: A looming cancer vaccine test for Gritstone Bio,...

.@adamfeuerstein previews the expected readout from Gritstone Bio’s neoantigen c...

Studies cited in abortion pill case are retracted due t...

The mifepristone studies were detracted due to flaws in the research and undiscl...

Gilead sours on the ‘don’t eat me’ business

Gilead will no longer develop magrolimab, a treatment targeting the “don’t eat m...

New pharma CEOs in the hot seat

Today’s hearing, led by Sen. Bernie Sanders, will be a crucial test for a new ge...

STAT+: Pharmalittle: We are reading about Catalent conc...

The European Medicines Agency will investigate any risks to the availability of ...

A neuropsychologist clarifies science on aging and memo...

What is the relationship between aging, memory loss, and overall cognition? That...

STAT+: Major generic maker Aurobindo cuts production at...

Aurobindo, one of the largest generic drug makers, has halted some production at...

STAT+: Senators start work on Medicare physician paymen...

A bipartisan group of senators is starting to work on long-term fixes to issues ...

Does Moderna’s RSV vaccine lose efficacy faster than ot...

Follow-up data from Moderna’s Phase 3 RSV vaccine trial reveals that its efficac...